MARKET

KYNB

KYNB

KYNTRA BIO INC
NASDAQ
9.41
-0.09
-0.95%
Opening 15:31 01/09 EST
OPEN
9.51
PREV CLOSE
9.50
HIGH
9.66
LOW
9.40
VOLUME
10.79K
TURNOVER
--
52 WEEK HIGH
21.94
52 WEEK LOW
4.850
MARKET CAP
38.07M
P/E (TTM)
0.1764
1D
5D
1M
3M
1Y
5Y
1D
*News On FibroGen Inc. (FGEN) Now Under KYNB
Dow Jones · 23h ago
FibroGen rebrands as Kyntra Bio, refocuses on oncology
TipRanks · 1d ago
FibroGen announces rebrand as Kyntra Bio
TipRanks · 2d ago
FIBROGEN INC - KYNTRA BIO TO TRADE UNDER SYMBOL 'KYNB' JANUARY 8
Reuters · 2d ago
FibroGen Rebrands as Kyntra Bio
Reuters · 2d ago
Weekly Report: what happened at FGEN last week (1229-0102)?
Weekly Report · 4d ago
Weekly Report: what happened at FGEN last week (1222-1226)?
Weekly Report · 12/29/2025 09:15
Weekly Report: what happened at FGEN last week (1215-1219)?
Weekly Report · 12/22/2025 09:15
More
About KYNB
FibroGen, Inc. is a biopharmaceutical company focused on the development of novel therapies at the frontiers of cancer biology and anemia. It is developing FG-3246, a potential first-in-class antibody-drug conjugate (ADC) targeting CD46, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and potentially other cancers. This program also includes the development of FG-3180, an associated CD46-targeted positron emission tomography (PET) biomarker and imaging agent. It is also developing Roxadustat, an oral medication, first-in-class, oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), which is evaluated for the treatment of anemia in patients with chronic kidney disease (CKD), anemia associated with myelodysplastic syndromes and chemotherapy-induced anemia. Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD).

Webull offers Kyntra Bio Inc stock information, including NASDAQ: KYNB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KYNB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KYNB stock methods without spending real money on the virtual paper trading platform.